Revenio Group Oyj (OTCMKTS:REVXF – Get Free Report) was the target of a significant increase in short interest in June. As of June 15th, there was short interest totaling 21,713 shares, an increase of 77.7% from the May 31st total of 12,217 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.
Revenio Group Oyj Stock Performance
Revenio Group Oyj stock opened at $16.41 on Friday. Revenio Group Oyj has a 12 month low of $16.41 and a 12 month high of $16.54. The stock’s 50 day simple moving average is $17.46 and its two-hundred day simple moving average is $20.29.
Revenio Group Oyj Company Profile
Revenio Group Oyj is a Finland‐based medical technology company specializing in ophthalmic diagnostic instruments. The company’s core business centers on the design, manufacture and sales of intraocular pressure (IOP) measurement devices that support glaucoma screening, diagnosis and long‐term patient monitoring. Utilizing patented rebound tonometry technology, Revenio’s tonometers provide rapid, non-invasive IOP readings without the need for topical anesthesia, making them well‐suited for both clinical and home settings.
Revenio’s product portfolio is anchored by the Icare® family of tonometers, which includes the Icare PRO for clinical use and the Icare HOME for patient self-monitoring.
Featured Articles
- Five stocks we like better than Revenio Group Oyj
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Revenio Group Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revenio Group Oyj and related companies with MarketBeat.com's FREE daily email newsletter.
